Navigation Links
Cell Therapeutics Reaches Agreement to Reacquire Rights to Two Anti-Cancer Compounds
Date:1/13/2014

ique structural and physiochemical properties. Unlike related compounds, PIXUVRI forms stable DNA adducts and in preclinical models has superior anti-lymphoma activity compared to related compounds. PIXUVRI was structurally designed so that it cannot bind iron and perpetuate oxygen radical production or form a long-lived hydroxyl metabolite -- both of which are the putative mechanisms for anthracycline induced acute and chronic cardiotoxicity.  These novel pharmacologic properties allow PIXUVRI to be administered to patients with near maximal lifetime exposure to anthracyclines without unacceptable rates of cardiotoxicity.

In May 2012, the European Commission (EC) granted conditional marketing authorization for PIXUVRI as a monotherapy for the treatment of adult patients with multiply relapsed or refractory aggressive NHL. The benefit of PIXUVRI treatment has not been established in patients when used as fifth line or greater chemotherapy in patients who are refractory to last therapy. The Summary of Product Characteristics (SmPC) has the full prescribing information, including the safety and efficacy profile of PIXUVRI in the approved indication. The SmPC is available at www.pixuvri.eu.

CTI is currently accruing patients into a Phase 3 trial comparing PIXUVRI and rituximab with gemcitabine and rituximab in the setting of aggressive B-cell NHL. PIXUVRI does not have marketing approval in the United States.

About Opaxio

Opaxio™ (paclitaxel poliglumex) is an investigational, biologically-enhanced chemotherapeutic that links paclitaxel, the active ingredient in Taxol®, to a biodegradable polyglutamate polymer, which results in a new chemical entity. When bound to the polymer, paclitaxel is inactive, potentially sparing normal tissue's exposure to high levels of paclitaxel and its associated toxicities. Blood vessels in tumor tis
'/>"/>

SOURCE Cell Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Sorrento Therapeutics to Present at the Biotech Showcase 2014 and the 7th Annual OneMed Forum SF2014 in San Francisco
2. PhaseRx Appoints Michael Houston, Ph.D., Vice President, Therapeutics Development
3. ImmunoCellular Therapeutics Issues Shareholder Letter Providing Update on ICT-107 Program in Newly Diagnosed Glioblastoma
4. Altheus Therapeutics announces completed enrollment of ZA201, a Phase 2 clinical trial of Zoenasa for distal ulcerative colitis
5. Liver Diseases Therapeutics Market (Chemotherapy, Anti-Virals, Vaccines, Targeted Therapy and Immunosuppressants) - Global Industry Analysis, Size, Share, Trends and Forecast, 2012 - 2018
6. Nektar Therapeutics President and CEO, Howard W. Robin, To Present at the 32nd Annual J.P. Morgan Healthcare Conference in San Francisco, CA
7. Flexion Therapeutics Files Registration Statement for Proposed Initial Public Offering
8. G1 Therapeutics to Present at Biotech Showcase 2014
9. Daiichi Sankyo, Virtici and Celdara Medical Announce Collaboration to Identify and Progress High Potential Therapeutics
10. Mast Therapeutics Provides Enrollment Update On Phase 3 "EPIC" Study Of MST-188
11. Revamped Therapies Preventing Visual Impairment Primed to Revolutionize US Retinal Therapeutics Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... OF SPAIN, Trinidad and Tobago , July ... Division of the Trinidad & Tobago Ministry of ... market, an innovative therapy that significantly increases the cure ... for patients infected with the genotype 1 virus. ... under the trade brand INCIVO®. ...
(Date:7/25/2014)... , July 25, 2014  Solanbridge Group Inc ... acquired the majority interest in Buzznbrewz.com and the Letter ... replaced with a fully executed Purchase Agreement. ... stated "We are proud to have Mr. David ... decades of experience in the private sector and developed ...
(Date:7/25/2014)... 25, 2014 Research and Markets ... Diagnostic Devices Market 2014-2018" report to their offering. ... About Ophthalmic Diagnostic Device An ophthalmic ... a defect or deficiency in the human visual pathway. ... such as presbyopia, cataracts, glaucoma, retinal disorders, conjunctivitis, and ...
Breaking Medicine Technology:The Hepatitis C virus is the main cause of liver transplant in the world 2The Hepatitis C virus is the main cause of liver transplant in the world 3Solanbridge Group Inc Announces Acquisition of Buzznbrewz.com 2Global Ophthalmic Diagnostic Devices Market 2014-2018: Key Vendors are Alcon, Carl Zeiss, Haag-Streit and Topcon 2
... Sept. 21, 2011 A new electronic medication system, the ... Hospital for Children at P/SL which adds a new ... right amount of medicine in an emergency situation. ... up calculations and reduce mistakes.  Dr. James Broselow, inventor of ...
... Research Partners is pleased to announce the recent closing ... Heart is a Minnesota-based medical device company that is ... contacting, heart assist therapy for the treatment of moderate ... a minimally invasive procedure. Sunshine Heart ...
Cached Medicine Technology:New Electronic Child Medication Safety System Launches at Rocky Mountain Hospital for Children at Presbyterian/St. Luke's Medical Center 2New Electronic Child Medication Safety System Launches at Rocky Mountain Hospital for Children at Presbyterian/St. Luke's Medical Center 3
(Date:7/26/2014)... Pools can provide much-needed relief from the summer heat, ... too much chlorinated water, experts warn. Amid the ... get water in their mouth. Some kids may even ... their parents. Although swallowing a small amount of ... realize that ingesting too much can lead to chlorine ...
(Date:7/26/2014)... As reported by Lauren Hunter ... on 3 factors: smaller spaces, multi-generational access, and water ... of 2014 lists, including this article on Freshome ... , a leading manufacturer of steam bath generators, has ... to smaller spaces and an effort to reduce water ...
(Date:7/26/2014)... As reported in this article ... research by Palo Alto Networks shows that Nigeria’s infamous ... focusing more on businesses and their digital treasures instead ... wise to their tactics over the years. Global ... talks about the evolution of 419 scams and what ...
(Date:7/26/2014)... (PRWEB) July 26, 2014 “Healthy teeth are ... keeping those pearly whites shining,” says Community Health Center of ... Healthy ." , They believe that an integration of medical ... healthy and well. Because of this, they encourage regular cleanings ... with dentist . , “Children and adults will find ...
(Date:7/26/2014)... Dallas, TX (PRWEB) July 26, 2014 ... sclerosis or encephalomyelitis disseminata, is an inflammatory disease ... in the brain and spinal cord are damaged. ... the nervous system to communicate, resulting in a ... mental, and sometimes psychiatric problems. Multiple sclerosis takes ...
Breaking Medicine News(10 mins):Health News:Don't Let Kids Drink Pool Water 2Health News:Amerec Finds Bathroom Design Trends Change Based on Water Consumption and Other Factors 2Health News:Businesses the New Target for Nigeria’s 419 Cyber-Scammers 2Health News:Businesses the New Target for Nigeria’s 419 Cyber-Scammers 3Health News:Businesses the New Target for Nigeria’s 419 Cyber-Scammers 4Health News:Businesses the New Target for Nigeria’s 419 Cyber-Scammers 5Health News:Businesses the New Target for Nigeria’s 419 Cyber-Scammers 6Health News:Common Dental Care Questions Answered by Community Health Center of Snohomish County in Recent Article 2Health News:Multiple Sclerosis Therapeutics Clinical Trials Market Review H2 2014 Analysis Report Available at MarketOptimizer.org 2Health News:Multiple Sclerosis Therapeutics Clinical Trials Market Review H2 2014 Analysis Report Available at MarketOptimizer.org 3Health News:Multiple Sclerosis Therapeutics Clinical Trials Market Review H2 2014 Analysis Report Available at MarketOptimizer.org 4
... (NYSE: ACS ) announced today that it ... provide information technology,outsourcing (ITO) services to Parkland Health ... Under the terms of the agreement, ACS will ... and management, asset tracking, and help desk support ...
... have correlated with prostate biopsy results in the detection ... for men with a normal prostate exam, according to ... issue of CANCER, a peer-reviewed journal of the American ... make PSA less useful in prostate cancer screening. , ...
... in Drosophila (fruit flies), have identified several drugs and small ... a frequent form of mental retardation and one of the ... stage for developing new treatments for fragile X syndrome. , ... PhD, chair of the Department of Human Genetics at Emory ...
... stretching program still evident 3 months later, study ... helps ease hot flashes and other menopausal symptoms in ... of the 37 women who,d had early stage breast ... program, while others were assigned to a control group. ...
... FRANCISCO Only 45 percent of baseball players were able ... level after shoulder or elbow surgery, according to new research ... Medicine Specialty Day at The Moscone Center. , ... percent of the players back to their pre-injury level or ...
... New research found only 45 percent of players return to same or higher ... ... percent of baseball,players were able to return to the game at the same ... during,the 2008 American Orthopaedic Society for Sports Medicine Specialty Day at,The Moscone Center., ...
Cached Medicine News:Health News:ACS Awarded $41 Million Contract to Provide IT Outsourcing Services to Parkland Hospital 2Health News:ACS Awarded $41 Million Contract to Provide IT Outsourcing Services to Parkland Hospital 3Health News:Biopsy techniques have made PSA test less predictive 2Health News:Drosophila drug screen for fragile X syndrome finds promising compounds and potential drug targets 2Health News:Yoga Eases Menopause Symptoms in Breast Cancer Survivors 2Health News:Comeback to a pre-injury level disappointing for professional baseball players 2Health News:Comeback to a Pre-Injury Level After Elbow or Shoulder Surgery Disappointing for Pro Baseball Players 2
Castroviejo straight tying forceps, straight shafts, 5 mm tying platforms, wide handle....
Microsurgical curved forceps made of titanium has curved shafts with smooth working surface. TCI working parts 6 mm from tips with round handle, diam. 6 mm, overall length 116 mm....
Girard curved tying forceps made of titanium has curved shafts with 8 mm tying platforms, width of shafts 0,25 mm, TCI platforms, round handle, diam. 6 mm, overall length 99 mm....
Angled tying forceps made of titanium has angled shafts with 6 mm V-grove tying platforms, width of shafts 0,5 mm, TCI platforms, flat handle, width 10 mm, overall length 102 mm....
Medicine Products: